榮盛石化(002493.SZ):本次美國關稅調整對公司成品油出口等整體海外業務無直接影響
格隆匯4月9日丨榮盛石化(002493.SZ)在投資者互動平臺表示,公司目前無出口美國的業務,也無原材料從美國進口,本次美國關稅調整對公司成品油出口等整體海外業務無直接影響。2024年以來,公司控股股東已展開兩期增持計劃,累計增持金額達16.93億元!基於看好國內資本市場長期投資的價值以及對榮盛石化未來持續穩定發展的信心,公司控股股東榮盛控股計劃啓動新一輪增持計劃,增持金額不低於人民幣10億元且不超過人民幣20億元。公司將以提高公司質量爲基礎,依法做好市值管理工作,進一步提升公司投資價值和股東回報能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.